Intra-Cellular Therapies
ITCI
#1801
Rank
S$12.05 B
Marketcap
$113.73
Share price
-0.36%
Change (1 day)
52.93%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.17

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.12. In 2022 the company made an earnings per share (EPS) of -$3.59 an increase over its 2021 EPS that were of -$4.62.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.17-39.63%
2022-$3.59-22.29%
2021-$4.628.02%
2020-$4.2720.9%
2019-$3.53-5.63%
2018-$3.7533.96%
2017-$2.80-21.19%
2016-$3.55-7.56%
2015-$3.84174.53%
2014-$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.33-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.19 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.82 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA